Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Lin, Jessica J JJ; Choudhury, Noura J NJ; Yoda, Satoshi S; Zhu, Viola W VW; Johnson, Ted W TW; Sakhtemani, Ramin R; Dagogo-Jack, Ibiayi I; Digumarthy, Subba R SR; Lee, Charlotte C; Do, Andrew A; Peterson, Jennifer J; Prutisto-Chang, Kylie K; Malik, Wafa W; Hubbeling, Harper G HG; Langenbucher, Adam A; Schoenfeld, Adam J AJ; Falcon, Christina J CJ; Temel, Jennifer S JS; Sequist, Lecia V LV; Yeap, Beow Y BY; Lennerz, Jochen K JK; Shaw, Alice T AT; Lawrence, Michael S MS; Ou, Sai-Hong Ignatius SI; Hata, Aaron N AN; Drilon, Alexander A; Gainor, Justin F JF
MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Sato, Hiroki H; Schoenfeld, Adam J AJ; Siau, Evan E; Lu, Yue Christine YC; Tai, Huichun H; Suzawa, Ken K; Kubota, Daisuke D; Lui, Allan J W AJW; Qeriqi, Besnik B; Mattar, Marissa M; Offin, Michael M; Sakaguchi, Masakiyo M; Toyooka, Shinichi S; Drilon, Alexander A; Rosen, Neal X NX; Kris, Mark G MG; Solit, David D; De Stanchina, Elisa E; Davare, Monika A MA; Riely, Gregory J GJ; Ladanyi, Marc M; Somwar, Romel R
Resistance Mechanisms to Targeted Therapies in ROS1+ and ALK+ Non-small Cell Lung Cancer.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
McCoach, Caroline E CE; Le, Anh T AT; Gowan, Katherine K; Jones, Kenneth K; Schubert, Laura L; Doak, Andrea A; Estrada-Bernal, Adriana A; Davies, Kurtis D KD; Merrick, Daniel T DT; Bunn, Paul A PA; Purcell, W Tom WT; Dziadziuszko, Rafal R; Varella-Garcia, Marileila M; Aisner, Dara L DL; Camidge, D Ross DR; Doebele, Robert C RC